annual accounts payable:
$258.69M+$115.12M(+80.18%)Summary
- As of today (August 16, 2025), AMRX annual accounts payable is $258.69 million, with the most recent change of +$115.12 million (+80.18%) on December 31, 2024.
- During the last 3 years, AMRX annual accounts payable has risen by +$127.61 million (+97.35%).
- AMRX annual accounts payable is now at all-time high.
Performance
AMRX Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$205.81M+$13.28M(+6.90%)Summary
- As of today (August 16, 2025), AMRX quarterly accounts payable is $205.81 million, with the most recent change of +$13.28 million (+6.90%) on June 30, 2025.
- Over the past year, AMRX quarterly accounts payable has increased by +$6.23 million (+3.12%).
- AMRX quarterly accounts payable is now -66.46% below its all-time high of $613.62 million, reached on September 30, 2020.
Performance
AMRX quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
AMRX Accounts payable Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +80.2% | +3.1% |
3 y3 years | +97.3% | -63.4% |
5 y5 years | +151.1% | -65.7% |
AMRX Accounts payable Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +97.3% | -63.4% | +47.5% |
5 y | 5-year | at high | +151.1% | -66.5% | +57.0% |
alltime | all time | at high | >+9999.0% | -66.5% | +194.0% |
AMRX Accounts payable History
Date | Annual | Quarterly |
---|---|---|
Jun 2025 | - | $205.81M(+6.9%) |
Mar 2025 | - | $192.53M(-25.6%) |
Dec 2024 | $258.69M(+80.2%) | $258.69M(+10.1%) |
Sep 2024 | - | $235.00M(+17.7%) |
Jun 2024 | - | $199.58M(+13.8%) |
Mar 2024 | - | $175.32M(+22.1%) |
Dec 2023 | $143.57M(-13.5%) | $143.57M(-19.1%) |
Sep 2023 | - | $177.40M(+27.1%) |
Jun 2023 | - | $139.53M(-70.1%) |
Mar 2023 | - | $467.42M(+181.6%) |
Dec 2022 | $165.98M(+26.6%) | $165.98M(-68.8%) |
Sep 2022 | - | $531.46M(-5.4%) |
Jun 2022 | - | $561.69M(+4.1%) |
Mar 2022 | - | $539.73M(+311.7%) |
Dec 2021 | $131.08M(-14.4%) | $131.08M(-77.8%) |
Sep 2021 | - | $589.41M(-1.1%) |
Jun 2021 | - | $596.23M(+3.8%) |
Mar 2021 | - | $574.32M(+275.0%) |
Dec 2020 | $153.14M(+48.6%) | $153.14M(-75.0%) |
Sep 2020 | - | $613.62M(+2.4%) |
Jun 2020 | - | $599.49M(-1.2%) |
Mar 2020 | - | $606.92M(+489.1%) |
Dec 2019 | $103.02M | $103.02M(-79.2%) |
Sep 2019 | - | $495.86M(-1.8%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2019 | - | $505.14M(-9.6%) |
Mar 2019 | - | $558.75M(+386.5%) |
Dec 2018 | $114.85M(+64.0%) | $114.85M(-7.8%) |
Sep 2018 | - | $124.54M(-26.3%) |
Jun 2018 | - | $169.05M(+141.4%) |
Dec 2017 | $70.01M(+18.8%) | $70.01M |
Dec 2016 | $58.95M(+4.7%) | - |
Dec 2015 | $56.33M(+76.1%) | - |
Dec 2014 | $31.98M(+19.2%) | - |
Dec 2013 | $26.82M(-35.1%) | - |
Dec 2012 | $41.34M(+80.1%) | - |
Dec 2011 | $22.95M(+22.0%) | - |
Dec 2010 | $18.81M(-19.2%) | - |
Dec 2009 | $23.30M(+82.0%) | - |
Dec 2008 | $12.80M(-24.3%) | - |
Dec 2007 | $16.90M(+16.1%) | - |
Dec 2006 | $14.55M(+15.1%) | - |
Dec 2005 | $12.64M(-44.5%) | - |
Dec 2003 | $22.78M(+202.6%) | - |
Dec 2002 | $7.53M(+88.4%) | - |
Dec 2001 | $4.00M(+75.6%) | - |
Dec 2000 | $2.28M(-4.8%) | - |
Dec 1999 | $2.39M(+157.8%) | - |
Dec 1998 | $927.00K | - |
FAQ
- What is Amneal Pharmaceuticals, Inc. annual accounts payable?
- What is the all time high annual accounts payable for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. annual accounts payable year-on-year change?
- What is Amneal Pharmaceuticals, Inc. quarterly accounts payable?
- What is the all time high quarterly accounts payable for Amneal Pharmaceuticals, Inc.?
- What is Amneal Pharmaceuticals, Inc. quarterly accounts payable year-on-year change?
What is Amneal Pharmaceuticals, Inc. annual accounts payable?
The current annual accounts payable of AMRX is $258.69M
What is the all time high annual accounts payable for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high annual accounts payable is $258.69M
What is Amneal Pharmaceuticals, Inc. annual accounts payable year-on-year change?
Over the past year, AMRX annual accounts payable has changed by +$115.12M (+80.18%)
What is Amneal Pharmaceuticals, Inc. quarterly accounts payable?
The current quarterly accounts payable of AMRX is $205.81M
What is the all time high quarterly accounts payable for Amneal Pharmaceuticals, Inc.?
Amneal Pharmaceuticals, Inc. all-time high quarterly accounts payable is $613.62M
What is Amneal Pharmaceuticals, Inc. quarterly accounts payable year-on-year change?
Over the past year, AMRX quarterly accounts payable has changed by +$6.23M (+3.12%)